. Author manuscript; available in PMC: 2018 Mar 22.

Published in final edited form as: Chronobiol Int. 2017 Nov 28;35(3):368–377. doi: 10.1080/07420528.2017.1407779

Table 2.

Associations with the scaling exponent α.

	B	95% CI	p-Value
α₂ at time scales 1.5–10 h
Disease	−0.074	−0.114–−0.034	0.014
Disease^* gender	−0.068^a	−0.113–−0.024	0.010
Age^* activity levels	0.003^b,^c	0.001–0.006	0.021
Only in patients
Radiotherapy^* activity levels	0.041^b	0.012–0.070	0.019
Δ = α₁–α₂
Disease	0.058	0.016–0.099	0.006
α₃ at time scales 10–24 h
Age	0.193^c	0.066–0.320	0.003
Activity levels	0.472^b	0.197–0.747	0.001
Age^* activity levels	−0.069^b,^c	−0.021–−0.116	0.004

Data represented factors included in the linear regression model that were best able to predict scaling exponent α at different time scales.

I.e., the disease effect is stronger in men than women.

B for higher activity level: increase of 100 counts per 1-minute epoch.

B for age: increase of 10 years.

interaction. Disease: NFMA or craniopharyngioma.